Evofem Biosciences, Inc.
EVFM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $3 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $10 | $6 | $1 | $6 |
| Inventory | $2 | $2 | $5 | $8 |
| Other Curr. Assets | $1 | $0 | $3 | $7 |
| Total Curr. Assets | $14 | $9 | $13 | $30 |
| Property Plant & Equip (Net) | $1 | $1 | $8 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $10 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $3 | $0 |
| Total NC Assets | $10 | $1 | $12 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $11 | $25 | $43 |
| Liabilities | – | – | – | – |
| Payables | $16 | $17 | $15 | $10 |
| Short-Term Debt | $46 | $43 | $68 | $111 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $18 | $12 | $11 | $16 |
| Total Curr. Liab. | $80 | $72 | $94 | $138 |
| LT Debt | $0 | $0 | $3 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $5 | $0 | $0 |
| Total NC Liab. | $15 | $5 | $3 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $5 | $7 |
| Total Liabilities | $95 | $77 | $97 | $142 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $5 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$898 | -$889 | -$939 | -$861 |
| AOCI | -$3 | -$1 | $50 | $5 |
| Other Equity | $829 | $823 | $817 | $751 |
| Total Equity | -$71 | -$67 | -$72 | -$100 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $11 | $25 | $43 |
| Net Debt | $45 | $43 | $68 | $108 |